Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity

Sponsor
Vanderbilt University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT03209960
Collaborator
Ipsen (Industry)
60
1
6
10

Study Details

Study Description

Brief Summary

The purpose of this study is to improve spasticity diagnosis through development of a simple physical examination guide for primary care providers to identify patients who would benefit from being referred to a movement disorders neurologist for a spasticity evaluation.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Bedside Referral Tool
  • Other: Neurological Examination

Detailed Description

The aim of this study is to improve spasticity (a form of muscle rigidity) diagnosis through development of a simple physical examination guide for primary care providers/clinicians. This guide will assist in the identification of patients who would benefit from being referred to a movement disorders neurologist for spasticity evaluation and subsequent treatment. The examination tool will be tested for bedside implementation in all consenting participants residing in Tennessee State Veteran's Home, which is a long-term care facility in Murfreesboro, TN. Each of the 140 residents will receive one neurological examination and two physical examinations guided by the referral tool. A medical record review will also be performed.

Study Design

Study Type:
Observational
Actual Enrollment :
60 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity
Actual Study Start Date :
Jan 30, 2018
Actual Primary Completion Date :
Aug 1, 2018
Actual Study Completion Date :
Aug 1, 2018

Outcome Measures

Primary Outcome Measures

  1. Sensitivity of Bedside Referral Tool [Up to three months after consent is obtained]

    Two Vanderbilt primary care providers (a nurse practitioner and a primary care physician) will examine all consented residents, guided by the bedside referral tool, to determine if a referral to a movement disorders neurologist is requires for a spasticity consultation. The findings of each exam will be recorded by the research coordinator, who will keep the results blinded from the other raters. Each rater's referral decision will be compared to the diagnosis made by the movement disorders neurologist.

Secondary Outcome Measures

  1. Specificity of Bedside Referral Tool [Up to three months after consent is obtained]

    Two Vanderbilt primary care providers (a nurse practitioner and a primary care physician) will examine all consented residents, guided by the bedside referral tool, to determine if a referral to a movement disorders neurologist is requires for a spasticity consultation. The findings of each exam will be recorded by the research coordinator, who will keep the results blinded from the other raters. Each rater's referral decision will be compared to the diagnosis made by the movement disorders neurologist.

  2. Spasticity Diagnosis [Up to three months after consent is obtained]

    There is no biomarker for spasticity. Therefore, the diagnosis will be made on physician impression. A neurologist trained in movement disorders will examine each consented patient to determine if they have spasticity. The severity of the subject's spasticity will be documented, including the following measures: presence of fixed contractures and presence of pain on movement.

  3. Inter-rater Reliability [Up to three months after consent is obtained]

    Two Vanderbilt primary care providers (a nurse practitioner and a primary care physician) will examine all consented residents, guided by the bedside referral tool, to determine if a referral to a movement disorders neurologist is requires for a spasticity consultation. The findings of each exam will be recorded by the research coordinator, who will keep the results blinded from the other raters. Agreement on spasticity referral between the two Vanderbilt primary care providers who performed the bedside examination will be determined.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Males or female subjects of any race, aged 18 and above

  • Resident of the selected long-term care facility

  • The subject, or if appropriate their medical decision maker, is willing and able to provide written informed consent.

Exclusion Criteria:
  • Subjects for whom participation in the study may cause medical harm

Contacts and Locations

Locations

Site City State Country Postal Code
1 Tennessee State Veterans' Homes Murfreesboro Tennessee United States 37130

Sponsors and Collaborators

  • Vanderbilt University Medical Center
  • Ipsen

Investigators

  • Principal Investigator: David Charles, M.D., Professor and Vice-Chairman of Neurology

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
David Charles, Professor and Vice-Chairman of Neurology; Chief Medical Officer, Vanderbilt Neuroscience Institute, Vanderbilt University Medical Center
ClinicalTrials.gov Identifier:
NCT03209960
Other Study ID Numbers:
  • 162074
First Posted:
Jul 6, 2017
Last Update Posted:
Oct 9, 2018
Last Verified:
Oct 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 9, 2018